| BSE: 524816 | Sector: Health care |
| NSE: NATCOPHARM | ISIN Code: INE987B01026 |
| BSE 00:00 | 15 Jan | 691.55 |
7.35 (1.07%) |
OPEN
686.00 |
HIGH
693.45 |
LOW
686.00 |
| NSE 00:00 | 15 Jan | 692.70 |
7.20 (1.05%) |
OPEN
685.50 |
HIGH
694.70 |
LOW
685.50 |
| OPEN | 686.00 |
| PREVIOUS CLOSE | 684.20 |
| VOLUME | 4447 |
| 52-Week high | 1045.95 |
| 52-Week low | 637.40 |
| P/E | 14.26 |
| Mkt Cap.(Rs cr) | 12,769 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company engaged in developing manufacturing and marketing of finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs). The company's focus is primarily on niche therapeutic areas and complex products. The company sells its products in over 40 countries. FDF products are sold in the United States I...> More
| Parameter | Values | ||
| Market Cap | ( cr) |
12,769 | |
| EPS - TTM | () |
[*S] | 48.48 |
| P/E Ratio | (X) | [*S] | 14.26 |
| Face Value | () |
2 | |
| Latest Dividend | (%) | 75.00 | |
| Latest Dividend Date | 20 Aug 2018 | ||
| Dividend Yield | (%) | 1.19 | |
| Book Value / Share | () |
[*S] | 188.75 |
| P/B Ratio | () |
[*S] | 3.66 |
Natco Pharma to commence Rs 2.5-billion share buyback on November 19
Natco Pharma looks to improve domestic revenues with more product launches
Fresh triggers kick in for Natco, market share gains for copaxone drug
Pharma shares in focus; Dr Reddy's, Biocon, Lupin, Natco Pharma up over 3%
Particulars ( cr) |
Sep 2018 | Sep 2017 | % Chg |
| Net Sales | 543.5 | 426.7 | 27.37 |
| Other Income | 40 | 5.5 | 627.27 |
| Total Income | 583.5 | 432.2 | 35.01 |
| Total Expenses | 323 | 304.8 | 5.97 |
| Operating Profit | 260.5 | 127.4 | 104.47 |
| Net Profit | 181.6 | 84.4 | 115.17 |
| Equity Capital | 36.9 | 34.9 | - |
| Company | Price() |
Chg (%) | Mkt Cap ( CR) |
| Glenmark Pharma. | 665.90 | -0.07 | 18791.70 |
| Abbott India | 8106.95 | 0.96 | 17227.27 |
| Sanofi India | 6228.20 | -0.81 | 14343.55 |
| Natco Pharma | 691.55 | 1.07 | 12769.47 |
| Pfizer | 2698.30 | 0.07 | 12344.72 |
| Jubilant Life | 716.15 | -0.78 | 11408.27 |
| Alembic Pharma | 599.60 | 0.23 | 11302.46 |
|
|
|
| Date | Broker | Action | Price | Report |
| 07/11 | Equirus Securities | Accumulate | 957 |  Details |
| Period | BSE | NSE | Sensex | NIFTY |
| 1 Week | -0.30% | -0.50% | 0.94% | 0.78% |
| 1 Month | -1.28% | -1.24% | 0.99% | 0.75% |
| 3 Month | -3.56% | -3.44% | 4.17% | 3.56% |
| 6 Month | -13.25% | -13.26% | -0.61% | -1.20% |
| 1 Year | -33.26% | -33.12% | 4.23% | 1.35% |
| 3 Year | 30.38% | 30.37% | 48.51% | 46.37% |
| Today's Low/High | 686.00 |
|
693.45 |
| Week Low/High | 680.90 |
|
700.00 |
| Month Low/High | 666.40 |
|
717.00 |
| YEAR Low/High | 637.40 |
|
1046.00 |
| All TIME Low/High | 1.60 |
|
1080.00 |
Copyrights © 2019 Business Standard Private Ltd. All rights reserved.
Promoters
Banks/FIs
FIIs
Insurance
Mutual Funds
Indian Public
Custodians
Other